Spots Global Cancer Trial Database for head
Every month we try and update this database with for head cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | NCT00496236 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | NCT00496236 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer | NCT00394147 | Head and Neck C... | pemetrexed gemcitabine | 18 Years - | Fox Chase Cancer Center | |
| Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor | NCT00377247 | Primary Advance... Squamous Cell C... | autologous mono... | 37 Years - | University of Pittsburgh | |
| Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer | NCT00226239 | Cancer | Docetaxel Cisplatin Cetuximab Radiation Thera... | 18 Years - | University of Pittsburgh | |
| The Effects of Upper Airway and Digestive Tract Tumors on the Immune System | NCT00001603 | Esophageal Neop... Head and Neck N... Laryngeal Neopl... Papilloma Squamous Cell C... | - | National Institutes of Health Clinical Center (CC) | ||
| A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer | NCT00496535 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN) | NCT01080066 | Carcinoma, Squa... | No Intervention | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Immune Therapy of HPV-induced Cancers | NCT01462838 | HPV-induced Can... | P16_37-63 | 18 Years - | Oryx GmbH & Co. KG | |
| Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck | NCT00195299 | Squamous Cell C... | Temsirolimus | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer | NCT00291707 | Head and Neck C... | Cetuximab Pemetrexed radiation thera... | 18 Years - | University of Pittsburgh | |
| Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer | NCT00222729 | Cancer | Pemetrexed Bevacizumab | 18 Years - | University of Pittsburgh | |
| NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | NCT03109158 | Carcinoma, Squa... | NC-6004 Cetuximab 5-FU | 18 Years - | NanoCarrier Co., Ltd. | |
| Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma | NCT00596219 | SQUAMOUS CELL C... | celecoxib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma | NCT03795610 | Head and Neck S... Head and Neck C... Head and Neck C... Head and Neck C... Head and Neck C... HPV-Related Car... HPV-Related Mal... HPV-Related Squ... | IPI-549 | 18 Years - | University of California, San Diego | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy | NCT04691310 | Lymphedema Head and Neck C... Kinesio Taping Therapy | Kinesio Tex Gol... | 18 Years - 70 Years | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | |
| Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer | NCT01187472 | Head and Neck C... | 59 Years - | University of Chicago | ||
| Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer | NCT01187472 | Head and Neck C... | 59 Years - | University of Chicago | ||
| The Effects of Upper Airway and Digestive Tract Tumors on the Immune System | NCT00001603 | Esophageal Neop... Head and Neck N... Laryngeal Neopl... Papilloma Squamous Cell C... | - | National Institutes of Health Clinical Center (CC) | ||
| Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer | NCT01326923 | Head and Neck S... | Cetuximab | 18 Years - | Louisiana State University Health Sciences Center Shreveport | |
| Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer | NCT00226239 | Cancer | Docetaxel Cisplatin Cetuximab Radiation Thera... | 18 Years - | University of Pittsburgh | |
| Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy | NCT01967927 | Squamous Cell C... | 18F-MISO | 18 Years - 80 Years | University of Arkansas | |
| Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck | NCT00519077 | Head and Neck N... | Gefitinib | 18 Years - | University of Chicago | |
| Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer | NCT00226239 | Cancer | Docetaxel Cisplatin Cetuximab Radiation Thera... | 18 Years - | University of Pittsburgh | |
| Immune Therapy of HPV-induced Cancers | NCT01462838 | HPV-induced Can... | P16_37-63 | 18 Years - | Oryx GmbH & Co. KG | |
| Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer | NCT00222729 | Cancer | Pemetrexed Bevacizumab | 18 Years - | University of Pittsburgh | |
| Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers | NCT01166542 | Carcinoma, Squa... | REOLYSIN Carboplatin Paclitaxel Placebo | 18 Years - | Oncolytics Biotech | |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma | NCT00753038 | Carcinoma, Squa... | REOLYSIN® Carboplatin Paclitaxel | 18 Years - | Oncolytics Biotech |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
